TSX:CRONPharmaceuticals
Cronos Group (TSX:CRON) Is Up 5.4% After Completing GrowCo Phase 2 Expansion Project – Has The Bull Case Changed?
In January 2026, Cronos Group reported the completion of Phase 2 expansion at its GrowCo facility, a project aimed at easing flower supply constraints and supporting additional growth momentum in 2026.
This development, combined with Cronos’s debt-free balance sheet and strong liquidity, underscores its relatively resilient financial footing within the cannabis sector.
Next, we’ll examine how the GrowCo Phase 2 expansion shapes Cronos Group’s investment narrative and its capacity-driven...